Finance

Lists
603387:SHA
Getein Biotech Inc
CNÂ¥9.17
-1.71%
(-0.16) 1D
Oct 16, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603387...
Open
CNÂ¥9.38
High
CNÂ¥9.69
Low
CNÂ¥9.06
Mkt. cap
4.89B
Avg. vol.
8.73M
Volume
8.53M
Dividend
3.27%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Sep 18, 2026
P/E ratio
15.70
52-wk high
CNÂ¥11.42
52-wk low
CNÂ¥7.37
EPS
CNÂ¥0.58
Shares outstanding
186.01M
No. of employees
2K
Open
CNÂ¥9.38
High
CNÂ¥9.69
Low
CNÂ¥9.06
Mkt. cap
4.89B
Avg. vol.
8.73M
Volume
8.53M
Dividend
3.27%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Sep 18, 2026
P/E ratio
15.70
52-wk high
CNÂ¥11.42
52-wk low
CNÂ¥7.37
EPS
CNÂ¥0.58
Shares outstanding
186.01M
No. of employees
2K
News stories
From web sources and news partners
About Getein Biotech Inc
CEO-
Employees1.73K
FoundedMar 8, 2002
Headquarters-
SectorMedical device
Websitebio-gp.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
245.00M
294.03M
267.50M
287.83M
Cost of goods sold
74.90M
104.16M
79.33M
98.45M
Cost of revenue
74.90M
104.16M
79.33M
98.45M
Research and development expenses
42.92M
31.00M
41.35M
41.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
84.83M
70.47M
70.85M
79.39M
Operating expense
132.97M
101.95M
112.82M
133.89M
Total operating expenses
207.86M
206.11M
192.15M
232.34M
Operating income
37.13M
87.92M
75.35M
55.49M
Other non operating income
-7.46M
6.42M
-2.79M
1.63M
EBT including unusual items
52.65M
64.52M
80.89M
123.85M
EBT excluding unusual items
41.32M
83.86M
77.67M
105.73M
Income tax expense
5.23M
2.79M
7.65M
13.35M
Effective tax rate
9.94%
4.33%
9.45%
10.78%
Other operating expenses
-2.98M
5.52M
-7.71M
11.97M
Net income
51.74M
60.12M
76.30M
107.99M
Net profit margin
21.12%
20.45%
28.52%
37.52%
Earnings per share
-
-
-
-
Interest and investment income
13.93M
-
7.58M
55.96M
Interest expense
-2.83M
-3.42M
-2.46M
-1.70M
Net interest expenses
11.10M
-3.42M
5.12M
54.26M
Depreciation and amortization charges
-
-
-
-
EBITDA
58.60M
108.45M
95.88M
77.48M
Gain or loss from assets sale
-589.65K
47.74K
-
-181.14K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps